Compare DKNG & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DKNG | DVA |
|---|---|---|
| Founded | 2011 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 10.1B |
| IPO Year | 2021 | 2002 |
| Metric | DKNG | DVA |
|---|---|---|
| Price | $25.33 | $154.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 29 | 4 |
| Target Price | $41.41 | ★ $156.75 |
| AVG Volume (30 Days) | ★ 16.6M | 1.3M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.05 | N/A |
| EPS | N/A | ★ 9.84 |
| Revenue | $6,054,525,000.00 | ★ $13,643,069,000.00 |
| Revenue This Year | $15.75 | $3.80 |
| Revenue Next Year | $12.94 | $3.04 |
| P/E Ratio | ★ N/A | $15.51 |
| Revenue Growth | ★ 26.99 | 6.46 |
| 52 Week Low | $21.01 | $101.00 |
| 52 Week High | $48.78 | $159.42 |
| Indicator | DKNG | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 48.50 | 68.10 |
| Support Level | $21.01 | $135.14 |
| Resistance Level | $36.46 | N/A |
| Average True Range (ATR) | 1.18 | 4.54 |
| MACD | 0.52 | -0.45 |
| Stochastic Oscillator | 78.66 | 69.73 |
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number-two or -three revenue share position across states where it competes. DraftKings is now live with online or retail sports betting in 28 states and i-gaming in 5 states, with both products available to around 40% of Canada's population. In 2024, sports revenue was 61% of total sales, i-gaming 32%, and fantasy and lottery 7%. The company plans to launch a predictive event platform in late 2025 and also operates a non-fungible token commission-based marketplace and develops and licenses online gaming products.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.